Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents

Christopher N. Mayhew, Lisa M. Perkin, Xiaoping Zhang, Julien Sage, Tyler Jacks, Erik S. Knudsen

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The retinoblastoma (RB) tumor suppressor has been proposed to function as a key mediator of cell cycle checkpoints induced by chemotherapeutic agents. However, these prior studies have relied on embryonic fibroblasts harboring chronic loss of RB, a condition under which compensation of RB functions is known to occur. Here we utilized primary adult fibroblasts derived from mice harboring loxP sites tanking exon 3 of the Rb gene to delineate the action of RB in the chemotherapeutic response. In this system we find that targeted disruption of Rb leads to little overt change in cell cycle distribution. However, these cells exhibited deregulation of RB/E2F target genes and became aneuploid following culture in the absence of RB. When challenged with both DNA damaging and antimetabolite chemotherapeutics, RB was required for primary adult cells to undergo DNA damage checkpoint responses and loss of RB resulted in enhanced aneuploidy following challenge. In contrast, following spontaneous immortalization and the loss of functional p53 signaling, the antimetabolite 5-fluorouracil (5-FU) failed to induce arrest despite the presence of RB. In these immortal cultures RB/E2F targets were deregulated in a complex, gene-specific manner and RB was required for the checkpoint response to camptothecin (CPT). Mechanistic analyses of the checkpoint responses in primary cells indicated that loss of RB leads to increased p53 signaling and decreased viability following both CPT and 5-FU treatment. However, the mechanism through which these agents act to facilitate cell cycle inhibition through RB were distinct. These studies underscore the critical role of RB in DNA-damage checkpoint signaling and demonstrate that RB mediates chemotherapeutic-induced cell cycle inhibition in adult fibroblasts by distinct mechanisms.

Original languageEnglish (US)
Pages (from-to)4107-4120
Number of pages14
JournalOncogene
Volume23
Issue number23
DOIs
StatePublished - May 20 2004

Fingerprint

Retinoblastoma
Antimetabolites
Camptothecin
Cell Cycle
Fibroblasts
Aneuploidy
Fluorouracil
DNA Damage
Retinoblastoma Genes
Cell Cycle Checkpoints
Genes

Keywords

  • Cell cycle checkpoints
  • Chemotherapeutics
  • Immortalization
  • Retinoblastoma tumor suppressor
  • Thymidylate synthase

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Mayhew, C. N., Perkin, L. M., Zhang, X., Sage, J., Jacks, T., & Knudsen, E. S. (2004). Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. Oncogene, 23(23), 4107-4120. https://doi.org/10.1038/sj.onc.1207503

Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. / Mayhew, Christopher N.; Perkin, Lisa M.; Zhang, Xiaoping; Sage, Julien; Jacks, Tyler; Knudsen, Erik S.

In: Oncogene, Vol. 23, No. 23, 20.05.2004, p. 4107-4120.

Research output: Contribution to journalArticle

Mayhew, CN, Perkin, LM, Zhang, X, Sage, J, Jacks, T & Knudsen, ES 2004, 'Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents', Oncogene, vol. 23, no. 23, pp. 4107-4120. https://doi.org/10.1038/sj.onc.1207503
Mayhew CN, Perkin LM, Zhang X, Sage J, Jacks T, Knudsen ES. Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. Oncogene. 2004 May 20;23(23):4107-4120. https://doi.org/10.1038/sj.onc.1207503
Mayhew, Christopher N. ; Perkin, Lisa M. ; Zhang, Xiaoping ; Sage, Julien ; Jacks, Tyler ; Knudsen, Erik S. / Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents. In: Oncogene. 2004 ; Vol. 23, No. 23. pp. 4107-4120.
@article{9dc2003d518d4c49b8858c3299d19a3f,
title = "Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents",
abstract = "The retinoblastoma (RB) tumor suppressor has been proposed to function as a key mediator of cell cycle checkpoints induced by chemotherapeutic agents. However, these prior studies have relied on embryonic fibroblasts harboring chronic loss of RB, a condition under which compensation of RB functions is known to occur. Here we utilized primary adult fibroblasts derived from mice harboring loxP sites tanking exon 3 of the Rb gene to delineate the action of RB in the chemotherapeutic response. In this system we find that targeted disruption of Rb leads to little overt change in cell cycle distribution. However, these cells exhibited deregulation of RB/E2F target genes and became aneuploid following culture in the absence of RB. When challenged with both DNA damaging and antimetabolite chemotherapeutics, RB was required for primary adult cells to undergo DNA damage checkpoint responses and loss of RB resulted in enhanced aneuploidy following challenge. In contrast, following spontaneous immortalization and the loss of functional p53 signaling, the antimetabolite 5-fluorouracil (5-FU) failed to induce arrest despite the presence of RB. In these immortal cultures RB/E2F targets were deregulated in a complex, gene-specific manner and RB was required for the checkpoint response to camptothecin (CPT). Mechanistic analyses of the checkpoint responses in primary cells indicated that loss of RB leads to increased p53 signaling and decreased viability following both CPT and 5-FU treatment. However, the mechanism through which these agents act to facilitate cell cycle inhibition through RB were distinct. These studies underscore the critical role of RB in DNA-damage checkpoint signaling and demonstrate that RB mediates chemotherapeutic-induced cell cycle inhibition in adult fibroblasts by distinct mechanisms.",
keywords = "Cell cycle checkpoints, Chemotherapeutics, Immortalization, Retinoblastoma tumor suppressor, Thymidylate synthase",
author = "Mayhew, {Christopher N.} and Perkin, {Lisa M.} and Xiaoping Zhang and Julien Sage and Tyler Jacks and Knudsen, {Erik S.}",
year = "2004",
month = "5",
day = "20",
doi = "10.1038/sj.onc.1207503",
language = "English (US)",
volume = "23",
pages = "4107--4120",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "23",

}

TY - JOUR

T1 - Discrete signaling pathways participate in RB-dependent responses to chemotherapeutic agents

AU - Mayhew, Christopher N.

AU - Perkin, Lisa M.

AU - Zhang, Xiaoping

AU - Sage, Julien

AU - Jacks, Tyler

AU - Knudsen, Erik S.

PY - 2004/5/20

Y1 - 2004/5/20

N2 - The retinoblastoma (RB) tumor suppressor has been proposed to function as a key mediator of cell cycle checkpoints induced by chemotherapeutic agents. However, these prior studies have relied on embryonic fibroblasts harboring chronic loss of RB, a condition under which compensation of RB functions is known to occur. Here we utilized primary adult fibroblasts derived from mice harboring loxP sites tanking exon 3 of the Rb gene to delineate the action of RB in the chemotherapeutic response. In this system we find that targeted disruption of Rb leads to little overt change in cell cycle distribution. However, these cells exhibited deregulation of RB/E2F target genes and became aneuploid following culture in the absence of RB. When challenged with both DNA damaging and antimetabolite chemotherapeutics, RB was required for primary adult cells to undergo DNA damage checkpoint responses and loss of RB resulted in enhanced aneuploidy following challenge. In contrast, following spontaneous immortalization and the loss of functional p53 signaling, the antimetabolite 5-fluorouracil (5-FU) failed to induce arrest despite the presence of RB. In these immortal cultures RB/E2F targets were deregulated in a complex, gene-specific manner and RB was required for the checkpoint response to camptothecin (CPT). Mechanistic analyses of the checkpoint responses in primary cells indicated that loss of RB leads to increased p53 signaling and decreased viability following both CPT and 5-FU treatment. However, the mechanism through which these agents act to facilitate cell cycle inhibition through RB were distinct. These studies underscore the critical role of RB in DNA-damage checkpoint signaling and demonstrate that RB mediates chemotherapeutic-induced cell cycle inhibition in adult fibroblasts by distinct mechanisms.

AB - The retinoblastoma (RB) tumor suppressor has been proposed to function as a key mediator of cell cycle checkpoints induced by chemotherapeutic agents. However, these prior studies have relied on embryonic fibroblasts harboring chronic loss of RB, a condition under which compensation of RB functions is known to occur. Here we utilized primary adult fibroblasts derived from mice harboring loxP sites tanking exon 3 of the Rb gene to delineate the action of RB in the chemotherapeutic response. In this system we find that targeted disruption of Rb leads to little overt change in cell cycle distribution. However, these cells exhibited deregulation of RB/E2F target genes and became aneuploid following culture in the absence of RB. When challenged with both DNA damaging and antimetabolite chemotherapeutics, RB was required for primary adult cells to undergo DNA damage checkpoint responses and loss of RB resulted in enhanced aneuploidy following challenge. In contrast, following spontaneous immortalization and the loss of functional p53 signaling, the antimetabolite 5-fluorouracil (5-FU) failed to induce arrest despite the presence of RB. In these immortal cultures RB/E2F targets were deregulated in a complex, gene-specific manner and RB was required for the checkpoint response to camptothecin (CPT). Mechanistic analyses of the checkpoint responses in primary cells indicated that loss of RB leads to increased p53 signaling and decreased viability following both CPT and 5-FU treatment. However, the mechanism through which these agents act to facilitate cell cycle inhibition through RB were distinct. These studies underscore the critical role of RB in DNA-damage checkpoint signaling and demonstrate that RB mediates chemotherapeutic-induced cell cycle inhibition in adult fibroblasts by distinct mechanisms.

KW - Cell cycle checkpoints

KW - Chemotherapeutics

KW - Immortalization

KW - Retinoblastoma tumor suppressor

KW - Thymidylate synthase

UR - http://www.scopus.com/inward/record.url?scp=2942558345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942558345&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1207503

DO - 10.1038/sj.onc.1207503

M3 - Article

C2 - 15064736

AN - SCOPUS:2942558345

VL - 23

SP - 4107

EP - 4120

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 23

ER -